The tumour suppressor miR-34c targets MET in prostate cancer cells

por Hagman, Z, Haflidadottir, B S, Ansari, M, Persson, M, Bjartell, A, Edsjö, A, Ceder, Y
Publicado 2013

miR-205 negatively regulates the androgen receptor and is associated with adverse outcome of prostate cancer patients

por Hagman, Z, Haflidadóttir, B S, Ceder, J A, Larne, O, Bjartell, A, Lilja, H, Edsjö, A, Ceder, Y
Publicado 2013